GEHC · GE HealthCare Technologies Inc.
$70.352026-05-17Sector: Healthcare; Industry: Medical - Healthcare Information Services; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Bull
$155
+120.2% vs market
Base · active
$126
+79.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($98 · $155) Analysts Range ($77 · $105) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $17.6B | — | 18.3% | 20.9% | $2.5B | −$3.2B | −$630MM | 8.5% | — | 108.9% | $2.3B | $4.88 | — |
| 2022.Q4 | $18.3B | 4.3% | 15.8% | 22.5% | $2.2B | −$249MM | $2.0B | 9.0% | — | 20.9% | $19.2B | $4.16 | — |
| 2023.Q4 | $19.6B | 6.6% | 14.3% | 31.5% | $1.9B | −$389MM | $1.5B | 8.6% | — | 10.4% | $17.6B | $3.41 | — |
| 2024.Q4 | $19.7B | 0.6% | 15.3% | 20.6% | $2.4B | −$560MM | $1.8B | 9.4% | — | 13.3% | $18.4B | $4.33 | — |
| 2025.Q4 | $19.6B | -0.4% | 15.2% | 20.9% | $2.4B | −$1.1B | $1.3B | 9.5% | — | 12.5% | $19.5B | $3.65 | 10.8 |
| italics below = DCF projection · 10yr Rev CAGR: 5.7% |
| 2026.Q4 | $21.7B | +10.6% | 15.5% | 20.8% | $2.7B | −$694MM | $2.0B | 9.3% | $1.8B | 13.4% | $20.2B | $5.01 | 14.0 |
| 2027.Q4 | $22.7B | +4.6% | 15.5% | 20.7% | $2.8B | −$361MM | $2.4B | 9.2% | $2.0B | 13.7% | $20.5B | $5.25 | 13.4 |
| 2028.Q4 | $23.8B | +5.0% | 15.5% | 20.6% | $2.9B | −$442MM | $2.5B | 9.2% | $1.9B | 14.1% | $21.0B | $5.52 | 12.7 |
| 2029.Q4 | $25.5B | +7.1% | 15.5% | 20.6% | $3.1B | −$718MM | $2.4B | 9.1% | $1.7B | 14.7% | $21.7B | $5.92 | 11.9 |
| 2030.Q4 | $26.9B | +5.7% | 15.5% | 20.5% | $3.3B | −$686MM | $2.6B | 9.0% | $1.7B | 15.0% | $22.4B | $6.26 | 11.2 |
|
| Term. Yr+ | $35.4B | 4.1% | 20.1% | 20.0% | $5.7B | −$1.2B | $4.5B | 8.6% | $42.4B | 19.7% | — | — | — |
Active scenario IV: $126 (+79.7% vs market)